Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer

NCT01857817 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

INDUSTRY

Sponsor class

Stopped Low patient recruitment

Conditions

Prostatic Neoplasms

Interventions

DRUG: VT-122
DRUG: Placebo

Sponsor

Vicus Therapeutics